相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。PD-L1 Mediates IFNγ-Regulation of Glucose but Not of Tryptophan Metabolism in Clear Cell Renal Cell Carcinoma
Mamatha Garige et al.
FRONTIERS IN ONCOLOGY (2022)
The Organoid Cell Atlas
Christoph Bock et al.
NATURE BIOTECHNOLOGY (2021)
Interferon-Gamma-Producing CD8+ Tissue Resident Memory T Cells Are a Targetable Hallmark of Immune Checkpoint Inhibitor-Colitis
Sarah C. Sasson et al.
GASTROENTEROLOGY (2021)
Next generation of anti-PD-L1 Atezolizumab with enhanced anti-tumor efficacy in vivo
Maohua Li et al.
SCIENTIFIC REPORTS (2021)
Unravelling Checkpoint Inhibitor Associated Autoimmune Diabetes: From Bench to Bedside
Linda Wu et al.
FRONTIERS IN ENDOCRINOLOGY (2021)
Avelumab internalization by human circulating immune cells is mediated by both Fc gamma receptor and PD-L1 binding
Hulin Jin et al.
ONCOIMMUNOLOGY (2021)
Current understanding of cancer-intrinsic PD-L1: regulation of expression and its protumoral activity
Pedram Yadollahi et al.
BMB REPORTS (2021)
Mouse pancreatic ductal organoid culture as a relevant model to study exocrine pancreatic ion secretion
Reka Molnar et al.
LABORATORY INVESTIGATION (2020)
Immune checkpoint inhibitor diabetes mellitus: a novel form of autoimmune diabetes
Z. Quandt et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2020)
Immune checkpoint signaling and cancer immunotherapy
Xing He et al.
CELL RESEARCH (2020)
Human organoids: model systems for human biology and medicine
Jihoon Kim et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2020)
Roles of IFN-γ in tumor progression and regression: a review
Dragica Jorgovanovic et al.
BIOMARKER RESEARCH (2020)
The Dark Side of IFN-: Its Role in Promoting Cancer Immunoevasion
Marija Mojic et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Programmed Cell Death-1 Inhibitor-Induced Type 1 Diabetes Mellitus
Katrien Clotman et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2018)
Interferon-gamma drives programmed death-ligand 1 expression on islet β cells to limit T cell function during autoimmune diabetes
Kevin C. Osum et al.
SCIENTIFIC REPORTS (2018)
Progress and Challenges in the Design and Clinical Development of Antibodies for Cancer Therapy
Juan C. Almagro et al.
FRONTIERS IN IMMUNOLOGY (2018)
Interferon gamma, an important marker of response to immune checkpoint blockade in non-small cell lung cancer and melanoma patients
Niki Karachaliou et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2018)
A bioassay to measure energy metabolism in mouse colonic crypts, organoids, and sorted stem cells
Yang-Yi Fan et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2015)
Organoid Models of Human and Mouse Ductal Pancreatic Cancer
Sylvia F. Boj et al.
CELL (2015)
Interferons as Inducers of Apoptosis in Malignant Cells
Kevin P. Kotredes et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2013)
Interferon gamma and glycemic status in diabetes associated with chronic pancreatitis
P. Pavan Kumar et al.
PANCREATOLOGY (2012)
The blockade of immune checkpoints in cancer immunotherapy
Drew M. Pardoll
NATURE REVIEWS CANCER (2012)
The impact of glycosylation on monoclonal antibody conformation and stability
Kai Zheng et al.
MABS (2011)
Fc gamma receptors as regulators of immune responses
Falk Nimmerjahn et al.
NATURE REVIEWS IMMUNOLOGY (2008)
Activating Fcγ receptors participate in the development of autoimmune diabetes in NOD mice
Yoshihiro Inoue et al.
JOURNAL OF IMMUNOLOGY (2007)
The influence of glycosylation on the thermal stability and effector function expression of human IgG1-Fc: properties of a series of truncated glycoforms
Y Mimura et al.
MOLECULAR IMMUNOLOGY (2000)
分享论文
